Defining the role of plasma cells in the establishment of KSHV infection in human tonsil
定义浆细胞在人扁桃体 KSHV 感染建立中的作用
基本信息
- 批准号:10318902
- 负责人:
- 金额:$ 34.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-20 至 2026-08-31
- 项目状态:未结题
- 来源:
- 关键词:AnatomyAntibodiesAutomobile DrivingB-Lymphocyte SubsetsB-LymphocytesBiological ModelsBiologyCell CountCell LineageCellsCellular biologyDiseaseEndothelial CellsEpithelial CellsEtiologyEventExposure toGenetic TranscriptionGoalsHIVHerpesviridaeHerpesviridae InfectionsHumanHuman Herpesvirus 8ImmuneImmune System DiseasesImmune systemImmunologicsIndividualInfectionInfectious AgentInflammatoryInvadedKaposi SarcomaLibrariesLinkLymphatic Endothelial CellsLymphocyteLymphoid TissueLymphoproliferative DisordersLyticLytic PhaseMaintenanceMalignant NeoplasmsMesenchymalModelingMorbidity - disease rateMucous MembraneMulticentric Angiofollicular Lymphoid HyperplasiaOncogenicOralOral cavityPersonsPlasma CellsPlayRecombinant ProteinsResearchRoleSalivaSignal TransductionSiteSpecimenSyndromeT-LymphocyteT-Lymphocyte SubsetsTestingTissuesTonsilTransplant RecipientsTropismViralVirusVirus DiseasesWorkbasecell typecytokinedesigninsightlatent infectionmortalitymutantnoveloral immunologyplasma cell differentiationprimary effusion lymphomaprogramstooltransmission processtumorviral transmission
项目摘要
Abstract/Project Summary
Kaposi sarcoma-associated herpesvirus (KSHV) is an oncogenic human herpesvirus, which causes Kaposi
sarcoma (KS) as well as B cell lymphoproliferative disorders in the absence of adequate immune control. KSHV-
associated tumors are a significant cause of morbidity and mortality in transplant patients and individuals with HIV-
disease. The oral cavity is an important site for KSHV biology because saliva is believed to be the primary mode of
person-to-person transmission for the virus. The tonsil and other oral lymphoid tissues represent a logical
anatomical site for early infection events because they are in contact with saliva and are rich in target cell types for
KSHV infection including endothelial cells and B lymphocytes. Despite this, the biology of KSHV in the human tonsil
remains poorly understood. We have developed an extensive library of human tonsil specimens and a robust ex
vivo infection model KSHV in tonsil-derived lymphocytes. Using these tools, we have recently discovered that
mature plasma cells are highly targeted early in KSHV infection and that KSHV-infected plasma cells display a
mixture of latent and lytic infection cycles. The current proposal will test several hypotheses: (1) plasma cell infection
serves as an amplification step which is important for the overall establishment of infection in tonsil lymphocytes,
(2) the KSHV-encoded cytokine vIL-6 is critical for establishment of KSHV infection in lymphocytes via manipulation
of plasma cell biology and (3) the T cell-derived cellular cytokine IL-21 supports KSHV dissemination by driving
differentiation of plasma cells, and can partially replace the function of vIL-6 in early infection. The results of this
research will provide critical mechanistic details that will enhance our understanding of early events in KSHV
transmission and the establishment of KSHV infection in the lymphocyte compartment.
摘要/项目摘要
卡波济肉瘤相关疱疹病毒(Kaposi sarcoma-associated herpesvirus,KSHV)是一种致癌的人类疱疹病毒,
肉瘤(KS)以及B细胞淋巴增生性疾病。KSHV-
相关肿瘤是移植患者和HIV感染者发病和死亡的重要原因,
疾病口腔是KSHV生物学的重要部位,因为唾液被认为是KSHV的主要传播方式。
人与人之间的传播扁桃体和其他口腔淋巴组织代表了一种逻辑的
因为它们与唾液接触并且富含用于早期感染事件的靶细胞类型,
KSHV感染包括内皮细胞和B淋巴细胞。尽管如此,人类扁桃体中KSHV的生物学
仍然知之甚少。我们已经建立了一个广泛的人类扁桃体标本库,
扁桃体来源的淋巴细胞中的体内感染模型KSHV。利用这些工具,我们最近发现,
成熟浆细胞在KSHV感染的早期是高度靶向的,并且KSHV感染的浆细胞显示出
潜伏性和溶解性感染循环的混合。目前的建议将测试几个假设:(1)浆细胞感染
用作对扁桃体淋巴细胞中感染的总体建立重要的扩增步骤,
(2)KSHV编码的细胞因子vIL-6对于通过操纵在淋巴细胞中建立KSHV感染是关键的
和(3)T细胞衍生的细胞因子IL-21支持KSHV传播,
vIL-6可促进浆细胞分化,并可部分替代vIL-6在感染早期的作用。的结果
研究将提供关键的机制细节,这将提高我们对KSHV早期事件的理解
传播和建立KSHV感染的淋巴细胞隔室。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jennifer E Totonchy其他文献
Jennifer E Totonchy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jennifer E Totonchy', 18)}}的其他基金
Defining the role of plasma cells in the establishment of KSHV infection in human tonsil
定义浆细胞在人扁桃体 KSHV 感染建立中的作用
- 批准号:
10684229 - 财政年份:2021
- 资助金额:
$ 34.12万 - 项目类别:
Defining the role of plasma cells in the establishment of KSHV infection in human tonsil
定义浆细胞在人扁桃体 KSHV 感染建立中的作用
- 批准号:
10491243 - 财政年份:2021
- 资助金额:
$ 34.12万 - 项目类别:
Identifying susceptibility factors for KSHV infection in human tonsil
确定人扁桃体 KSHV 感染的易感因素
- 批准号:
9893850 - 财政年份:2019
- 资助金额:
$ 34.12万 - 项目类别:
Identifying susceptibility factors for KSHV infection in human tonsil
确定人扁桃体 KSHV 感染的易感因素
- 批准号:
9765880 - 财政年份:2019
- 资助金额:
$ 34.12万 - 项目类别:
Identifying susceptibility factors for KSHV infection in human tonsil
确定人扁桃体 KSHV 感染的易感因素
- 批准号:
10378747 - 财政年份:2019
- 资助金额:
$ 34.12万 - 项目类别:
Identifying susceptibility factors for KSHV infection in human tonsil
确定人扁桃体 KSHV 感染的易感因素
- 批准号:
10596565 - 财政年份:2019
- 资助金额:
$ 34.12万 - 项目类别:
Factors Influencing KSHV Infection and Spread within the Oral Cavity
影响 KSHV 口腔内感染和传播的因素
- 批准号:
9420193 - 财政年份:2016
- 资助金额:
$ 34.12万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 34.12万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 34.12万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 34.12万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 34.12万 - 项目类别:
Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 34.12万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 34.12万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 34.12万 - 项目类别:
Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
- 批准号:
10699504 - 财政年份:2023
- 资助金额:
$ 34.12万 - 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
- 批准号:
10491642 - 财政年份:2023
- 资助金额:
$ 34.12万 - 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
- 批准号:
10782567 - 财政年份:2023
- 资助金额:
$ 34.12万 - 项目类别: